Cancer News and Research

Latest Cancer News and Research

NIOSH funds the DUSTI project

In the construction industry, respiratory disease, often leading to disability or an increased risk of cancer, is a major public health concern. Studies led by Deborah Young-Corbett, a faculty member in Virginia Tech's School of Construction, have shown that specific types of sanding tools are highly effective in reducing the dust that causes these health hazards, yet the industry's usage of the available technology remains very low.

10 Nov 2009

Prepubertal boys with cancer can bank on their testicular tissue for preserving fertility

For parents of children with cancer, the hopeful news is that pediatric survival rates have steadily improved for decades. Among the bad news-treatments that enable survival often cause infertility.

10 Nov 2009

UOHI to receive $5.4M federal funds for development of new alternative radioisotope imaging tracers

Researchers from the University of Ottawa Heart Institute (UOHI) will receive nearly half of a $5.4 million federal fund to help solve a shortage of medical isotopes resulting from the shutdown of the Chalk River nuclear reactor. Two research teams will develop two new alternative radioisotope imaging tracers, test new applications for their use in diagnosing heart disease, and fast track production and distribution as quickly as possible across Canada.

10 Nov 2009

Landauer announces GPS acquisition

Landauer, Inc. (NYSE: LDR), a recognized leader in personal and environmental radiation monitoring services, today announced the completion of two acquisitions in accordance with its long-term strategic priorities.

10 Nov 2009

EpiCept announces third quarter 2009 financial results

EpiCept Corporation today announced operating and financial results for the three and nine months ended September 30, 2009, and provided an update on Ceplene® and several of the Company’s key product candidates.

10 Nov 2009

Low doses of amyloid beta protein in healthy brains can cause Alzheimer's disease, say scientists

While too much amyloid beta protein in the brain is linked to the development of Alzheimer's disease, not enough of the protein in healthy brains can cause learning problems and forgetfulness, Saint Louis University scientists have found.

10 Nov 2009

University of Michigan to develop novel therapy for neuropathic pain

Researchers from the University of Michigan Department of Neurology have received a $1.8 million dollar grant to develop a novel therapy for neuropathic pain, a difficult to treat condition in which patients experience pain because of damage to nerve without obvious tissue injury.

10 Nov 2009

New technique to identify patients more likely to survive advanced melanoma

Although the chances of surviving advanced melanoma aren't very good with current therapies, some patients can live for years with cancer that has spread beyond the skin to other organs. Now it may be possible to identify which patients are more likely to survive by analyzing the activity of hundreds of genes involved in the immune response and gene proliferation, according to researchers at NYU Langone Medical Center.

10 Nov 2009

FDA approves Istodax for treatment of Cutaneous T-cell Lymphoma

The U.S. Food and Drug Administration has approved Istodax (romidepsin), an injectable medication, for treatment of patients with a rare form of cancer known as Cutaneous T-cell Lymphoma (CTCL).

10 Nov 2009

FDA accepts ChemGenex Pharmaceuticals' NDA for Omapro

ChemGenex Pharmaceuticals Limited announced today that the U.S. Food & Drug Administration (FDA) has accepted the company’s New Drug Application (NDA) for Omapro™ (omacetaxine mepesuccinate) for the treatment of patients with chronic myeloid leukemia (CML) who have failed treatment with imatinib and who have developed the Bcr-Abl T315I mutation.

10 Nov 2009

WHO report calls for improved health care for women, girls

A new WHO report, released Monday, said women tend to "receive poorer quality care throughout their lives, particularly as teenagers and elderly people" even though they live six to eight years longer than men, Reuters reports. The WHO said women worldwide are "'denied a chance to develop their full human potential' because many of their critical medical needs are ignored" (MacInnis, 11/9).

10 Nov 2009

Awareness campaign for Children’s Neuroblastoma Cancer Foundation wins GCG Marketing honors

GCG Marketing today announces its award of Best Corporate Advertisement/Campaign at the 2009 Medical Marketing & Media Awards honoring the agency’s development of an awareness campaign for the Children’s Neuroblastoma Cancer Foundation.

9 Nov 2009

St. Jude Children's Research Hospital patients to receive proton therapy at the UF Proton Therapy Institute

St. Jude Children's Research Hospital and the University of Florida Proton Therapy Institute have formed a collaboration to provide proton therapy for St. Jude patients. The announcement follows the approval of the first clinical study to evaluate the use of proton therapy for rare brain cancers in children younger than 3 years old.

9 Nov 2009

Black Diamond Video’s Integrated Digital Surgical Suites to be installed at the Yale-New Haven Hospital

Black Diamond Video, Inc. announces that Yale-New Haven Hospital has selected BDV to install their state-of-the-art Integrated Digital Surgical Suites (IDSS) into their neurosurgical suite and gastrointestinal suites in the new Smilow Cancer Center.

9 Nov 2009

Scientific article supports AEterna Zentaris' development of perifosine inhibitor

AEterna Zentaris Inc., a global biopharmaceutical company focused on endocrine therapy and oncology, today announced publication of a scientific article in the renowned Journal of Urology, supporting the development of the Company's PI3K/Akt pathway inhibitor oral compound, perifosine, for the treatment of cancer.

9 Nov 2009

Smoking has a direct negative impact on postoperative outcomes

With the American Cancer Society's Great American Smokeout Challenge just a week away, the American Society of Anesthesiologists (ASA) is giving smokers yet another reason to quit. The scientific evidence is clear -- smoking has a direct negative impact on postoperative outcomes. Quitting smoking is one of the best things people can do to improve their chances of recovering from surgery without complications.

9 Nov 2009

Chicago Prostate Cancer Center offers free prostate cancer guide

Prostate cancer is the second most common cancer in American men. One in six men will be diagnosed during his lifetime, according to the American Cancer Society.

9 Nov 2009

CytRx reports financial results for the three months and nine months ended September 30, 2009

CytRx Corporation, a biopharmaceutical company, today reported financial results for the three months and nine months ended September 30, 2009.

9 Nov 2009

Enzon Announces to sell its specialty pharmaceutical business to the sigma-tau Group for $300 million

Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today announced that it has entered into a definitive agreement to sell its specialty pharmaceutical business to the sigma-tau Group for $300 million plus an additional amount of up to $27 million based on success milestones. Enzon will also receive royalties of 5 to 10 percent on incremental net sales above a 2009 baseline amount from Enzon’s four marketed specialty pharmaceutical products through 2014.

9 Nov 2009

Decision Resources forecasts sales of HER2-targeting agents to grow by 3.3% per year

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in 2008, human epidermal growth factor receptor 2 (HER2) targeting therapies -- which include Roche/Chugai's Herceptin and GlaxoSmithKline/Nippon Kayaku's Tykerb/Tyverb -- were the highest-selling drug class in breast cancer treatment.

9 Nov 2009

Cancer News and Research

Latest Cancer News and Research

NIOSH funds the DUSTI project

Prepubertal boys with cancer can bank on their testicular tissue for preserving fertility

UOHI to receive $5.4M federal funds for development of new alternative radioisotope imaging tracers

Landauer announces GPS acquisition

EpiCept announces third quarter 2009 financial results

Low doses of amyloid beta protein in healthy brains can cause Alzheimer's disease, say scientists

University of Michigan to develop novel therapy for neuropathic pain

New technique to identify patients more likely to survive advanced melanoma

FDA approves Istodax for treatment of Cutaneous T-cell Lymphoma

FDA accepts ChemGenex Pharmaceuticals' NDA for Omapro

WHO report calls for improved health care for women, girls

Awareness campaign for Children’s Neuroblastoma Cancer Foundation wins GCG Marketing honors

St. Jude Children's Research Hospital patients to receive proton therapy at the UF Proton Therapy Institute

Black Diamond Video’s Integrated Digital Surgical Suites to be installed at the Yale-New Haven Hospital

Scientific article supports AEterna Zentaris' development of perifosine inhibitor

Smoking has a direct negative impact on postoperative outcomes

Chicago Prostate Cancer Center offers free prostate cancer guide

CytRx reports financial results for the three months and nine months ended September 30, 2009

Enzon Announces to sell its specialty pharmaceutical business to the sigma-tau Group for $300 million

Decision Resources forecasts sales of HER2-targeting agents to grow by 3.3% per year

Understanding the DNA Damage Response in Innate Immunity eBook

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Newsletters you may be interested in